Found 43 matching trials
Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes
PHASE3This mechanistic study is designed to investigate the effect of vildaglipti...
VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus
PHASE4The purpose of this study was to determine whether the initiation of a vild...
Location
Novartis Investigative Site
A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes
PHASE3This study is not being conducted in the United States. Vildagliptin is an ...
Location
Novartis Pharmaceuticals
Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion
PHASE1The present study is a phase I, single-centre, double-blind, randomized, cr...
Location
Diabeteszentrum Bad Lauterberg
Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin
PHASE3This mechanistic study will evaluate the effect of vildagliptin on glucose-...
Location
Diabetes Zentrum Bad Lauterberg
Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 Diabetes
PHASE3The purpose of this study is to demonstrate the efficacy and safety of vild...
Location
Novartis Investigative Site
GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes
PHASE4To determine the extent to which the effects of treatment with LAF237 100 m...
Location
Diabeteszentrum Bad Lauterberg
Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes
PHASE4The study will demonstrate the effect of 24 weeks of treatment with vildagl...
Location
Novartis Investigative Site
Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus
PHASE3To assess the efficacy and safety of vildagliptin add-on therapy to reduce ...
Location
Novartis Investigative Site
Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes
PHASE3The purpose of the study is to evaluate the efficacy and safety of vildagli...
Location
Novartis Investigative Site